It suggested that the eight markers: MAPT, SIX3, MIR663, EPB41L3, FAM150A, TRIM73, LOC100128977, and LOC100130148 may serve as potential biomarkers for the early diagnosis of pancreatic cancer. This evidence concerns the gene MAPT and familial pancreatic carcinoma.